- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Coagulation; Intravascular in United States
Total 940 results
-
Bio Products LaboratoryCompletedFactor X DeficiencyUnited States, Turkey, Germany, Spain, United Kingdom
-
Newark Beth Israel Medical CenterGenentech, Inc.Not yet recruiting
-
Baxalta now part of ShireTerminatedHemophilia A | Hemophilia B | Bone Mineral DensityUnited States
-
PfizerCompletedBlood CoagulationUnited States
-
Bioverativ, a Sanofi companyCompletedVon Willebrand's Disease (VWD)France, United States
-
Genzyme, a Sanofi CompanyCompletedHemophilia A | Hemophilia BBulgaria, United States, United Kingdom, Russian Federation, Switzerland
-
CSL BehringEnrolling by invitation
-
SanofiRecruitingHemophilia AUnited States
-
Swedish Orphan BiovitrumBioverativ Therapeutics Inc.CompletedHemophilia AIreland, United Kingdom, Germany, United States, Canada, Slovenia, Sweden
-
Emory UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedHemophilia AUnited States
-
CSL BehringRecruiting
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia B | HaemostasisUnited States
-
BayerUltragenix pharmaceuticalActive, not recruitingHemophilia ANetherlands, United States, Germany, United Kingdom, France, Bulgaria
-
University of PennsylvaniaCompletedFocus of Study | Coagulation Status of Cardiac Surgery Patient | Reducing Excess Blood TransfusionUnited States
-
Hoffmann-La RocheRecruitingHemophilia ASpain, Canada, United States, New Zealand, Italy, Poland
-
Margaret RagniWyeth is now a wholly owned subsidiary of Pfizer; University of North CarolinaCompletedVon Willebrand DiseaseUnited States
-
PfizerActive, not recruiting
-
Emory UniversityGenentech, Inc.Withdrawn
-
PfizerTerminatedHemophilia AUnited States, New Zealand
-
Catalyst BiosciencesTerminatedPrevious Diagnosis With a Complement-mediated Disease and/or With Clinical Manifestations Reasonably Associated With Complement Factor I DeficiencyUnited States
-
Bioverativ Therapeutics Inc.CompletedSevere Hemophilia AUnited States, Hong Kong, Israel
-
Wyeth is now a wholly owned subsidiary of PfizerWithdrawnHemophilia AItaly, United States, Netherlands, United Kingdom, Germany, New Zealand, Belgium, France
-
SanofiCompletedHemophilia A | Hemophilia BBulgaria, Switzerland, United Kingdom, United States, Russian Federation
-
OctapharmaCompletedCongenital Fibrinogen Deficiency | AfibrinogenemiaIran, Islamic Republic of, United States, Bulgaria, India, Switzerland, United Kingdom
-
University of WashingtonGenentech, Inc.Recruiting
-
Bioverativ Therapeutics Inc.Swedish Orphan Biovitrum; Syntonix Pharmaceuticals, Inc.Completed
-
Ultragenyx Pharmaceutical IncTerminatedHemophilia BUnited States, United Kingdom, Bulgaria
-
BioMarin PharmaceuticalActive, not recruitingHemophilia AUnited States, Australia, Taiwan, Brazil
-
OctapharmaCompletedHemophilia AUnited States, Germany, Bulgaria
-
Laboratoire français de Fractionnement et de BiotechnologiesLFB USA, Inc.CompletedHemophiliaUnited States, Ukraine, Mexico, Russian Federation, South Africa, Spain
-
Baxalta now part of ShireCompleted
-
CSL BehringCompleted
-
Royal Free Hospital NHS Foundation TrustUnknown
-
Baxalta now part of ShireCompleted
-
Genentech, Inc.Terminated
-
Bioverativ, a Sanofi companyCompletedHemophilia AUnited States, Japan
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Duke UniversityGrifols Biologicals, LLCCompletedATIII DeficiencyUnited States
-
Rockefeller UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingGlanzmann ThrombastheniaUnited States
-
Spark TherapeuticsCompletedHematologic Diseases | Hemophilia A | Blood Coagulation Disorders, Inherited | Coagulation Protein Disorders | Hemorrhagic Disorders | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Blood Coagulation Disorder | Factor VIII DeficiencyUnited States, Australia, Thailand, Canada
-
East Kent Hospitals University NHS Foundation TrustNot yet recruitingHaemophiliaUnited Kingdom
-
PfizerCompletedHemophilia A or BUnited States, Chile, Croatia, Poland, South Africa, Switzerland
-
OPKO Health, Inc.CompletedHemophilia A | Hemophilia BUnited States
-
OctapharmaCompletedSevere Hemophilia AUnited States, France, Canada, United Kingdom, India, Georgia, Moldova, Republic of, Poland, Ukraine
-
BloodworksErgomed; Octapharma; Mary M. Gooley Hemophilia CenterRecruiting
-
Baxalta now part of ShireTerminatedHemophiliaUnited Kingdom
-
Wyeth is now a wholly owned subsidiary of PfizerWithdrawnHemophilia ABelgium, Italy, Spain, United States, United Kingdom, Germany, France